Pulmonary adenocarcinoma Issues, Issues and more issues. Why the headache?

Size: px
Start display at page:

Download "Pulmonary adenocarcinoma Issues, Issues and more issues. Why the headache?"

Transcription

1 Issues Pulmonary adenocarcinoma Issues, Issues and more issues. Why the headache? Classification Multiple nodules Invasive size Alain Borczuk, MD Weill Cornell Medicine Chronic headache - Classification International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. Travis, William; Brambilla, Elisabeth; Noguchi, Masayuki; Nicholson, Andrew; Geisinger, Kim; Yatabe, Yasushi; Beer, David; Powell, Charles; Riely, Gregory; Van Schil, Paul; Garg, Kavita; Austin, John; Asamura, Hisao; Rusch, Valerie; Hirsch, Fred; Scagliotti, Giorgio; Mitsudomi, Tetsuya; Huber, Rudolf; Ishikawa, Yuichi; Jett, James; Sanchez-Cespedes, Montserrat; Sculier, Jean-Paul; Takahashi, Takashi; Tsuboi, Masahiro; Vansteenkiste, Johan; Wistuba, Ignacio; Yang, Pan-Chyr; Aberle, Denise; Brambilla, Christian; Flieder, Douglas; Franklin, Wilbur; Gazdar, Adi; Gould, Michael; MD, MS; Hasleton, Philip; Henderson, Douglas; Johnson, Bruce; Johnson, David; Kerr, Keith; Kuriyama, Keiko; Lee, Jin; Miller, Vincent; Petersen, Iver; MD, PhD; Roggli, Victor; Rosell, Rafael; Saijo, Nagahiro; Thunnissen, Erik; Tsao, Ming; Yankelewitz, David Journal of Thoracic Oncology. 6(2): , February DOI: /JTO.0b013e318206a International Association for the Study of Lung Cancer. Published by Lippincott Williams & Wilkins, Inc.

2 Ground glass opacity - GGO Adenocarcinoma-in-situ (nonmucinous) Adenocarcinoma in situ Gross pathology Gross - Adenocarcinoma in situ (non-mucinous BAC) Usually less than 3.0 cm. No central depression/scarring No pleural thickening or puckering. Often ill defined, difficult to palpate. Slightly paler than adjacent lung, slightly raised does not collapse as much.

3 Adenocarcinoma in situ (non-mucinous) - histology Alveolar architecture/ no architectural effacement No broad area of scarring/ central scarring. Alveolar macrophages can be seen. Alveolar walls often thickened. Adenocarcinoma in situ Non-mucinous Alveolar architecture maintained HISTOLOGY high power Adenocarcinoma in situ (non-mucinous BAC) Airspaces to center Vessels and elastic tissue like normal lung Alveolar architecture Cells are cuboidal to low columnar Nuclear grade is variable, usually low Alveolar walls have increased collagen and elastic tissue. Often retained alveolar macrophages. Little to no stratification. No true papillae.

4 Problem area in recognizing alveolar architecture - Lepidic involvement of emphysema Minimally invasive adenocarcinoma, nonmucinous. Indolent, non-metastatic Gross size < 3.0 cm, invasive size < =5.0 mm What do you call the biopsy? Previously Adenocarcinoma, BAC pattern or features, nonmucinous. Now Lepidic pattern adenocarcinoma, nonmucinous

5

6 What about invasion over 5.0 mm? There does seem to be a relationship between invasive size and survival, and in lepidic predominant tumors may be a better predictor than gross size However, over 5.0 mm, every series shows a low but demonstrable rate of lymph node metastasis.

7 Lepidic predominant with 0.8 cm of invasion Lepidic predominant with 0.8 cm of invasion PAPILLARY ACINAR

8 SOLID MICROPAPILLARY Reproducibility Patterns - ring study confirmed reproducibility Typical patterns.77, lepidic and solid was best Difficult patterns.38 Papillary vs micropapillary poorest Allowing choice of secondary patterns reduced reproducibility Why enumerate invasive patterns? May help in future molecular classification/correlations. May have prognostic value (e.g. solid, micropapillary) In multiple nodules, histologic patterns may be evidence for metastasis or synchronous primary. Thunnissen et al, Mod Pathol 2012

9 Yoshizawa et al, Mod Pathol 2011 Borczuk, AC Eur Respir Rev Dec;25(142): Bigger headache Multiple nodules AJCC 8 th Edition - Springer

10 Multiple nodules as separate primaries Different histology Squamous with CIS component Different comprehensive histologic assessment AIS, MIA or LPA Not pneumonic type (often mucinous) Different oncogenic driver Exactly matching CGH Radiologically Distinct Multiple nodules - Resolvable

11 Multiple nodules - difficult KRAS G12D,EGFR no mutation KRAS and EGFR no mutations Acinar patterns are common Do they mean common primary? AJCC 8 th Edition

12 AJCC 8 th Edition - Multiple ground glass nodules History T2a N0 right upper lobe adenocarcinoma 4 years prior Detected after a staging procedure for a suspected leg sarcoma (non-neoplastic ultimately) Former smoker, 50 pack year 1.1 cm but with pleural invasion EGFR and ALK negative CURRENT CT SCAN History Left Right Right lung nodule was biopsied and negative Reduced interval size Left upper lobe was semisolid and showed increased FDG-PET avidity Radiation therapy was recommended but patient obtained 2 nd opinion Biopsied lepidic pattern adenocarcinoma Left upper lobectomy was performed All nodal stations were negative

13 Left upper lobectomy Staging AJCC 8 th Edition Tumor 1 - Lepidic predominant, 0.9 cm invasion or T1a (not MIA) correct 2.0 cm to 1.0 for invasive size 1 3 Tumor 2 - Lepidic predominant, 0.7 cm invasion or T1a (also invasive size) 2 Tumor 3 AIS 4-5 Tumor 4 Minimally invasive, 0.3 cm AJCC 8 th Edition (paraphrased) Table 36.9 Pathological criteria identifying multifocal Ground glass or lepidic lung adenocarcinoma Tumors should be considered multifocal lung adenocarcinoma if: There are multiple foci of LPA, MIA or AIS Foci of AAH are not counted This applies regardless of detailed histologic assessment Applies to clinical or pathology only detection Staging AJCC 8 th Edition Tis, T1a (mi), T1a. Highest T is T1a So, T1a (4/m) then N0 (in this case) AJCC 8 th edition, Springer

14 AJCC 8 th Edition - Multiple ground glass nodules TP53 c.711g>t, p.m237i Lepidic predominant BRAF c.1742a>g, p.n581s AIS Lepidic predominant EGFR c.2573t>g, p.l858r in Exon 21 BRAF c.1803a>t, p.k601n MIA EGFR c.2281g>t, p.d761y in Exon 19 AJCC 8 th edition pneumonic type AdCA What about pneumonia-like BAC? Not a solitary mass, replaces whole segment/lobe. This is not AIS. In my experience either mucinous or have a non-lepidic component.

15

16 AJCC 8 th Edition - pneumonic type AdCA Biggest headache Staging and invasive size pt changes size strata T AIS T1 MI T1 T1a: <=1.0, T1b <= 2.0 cm, T1c <= 3.0 cm With N0 1A1, 1A2, 1A3 T2 T2a: = >3 or <= 4 or <= 3 with pleural invasion T2 T2b: >4 or <=5 cm T3 - >5 or <= 7.0 cm T4: > 7.0 cm

17 pt changes other changes T2: lobar atelectasis Mediastinal pleura invasion no longer impacts stage T4: Diaphragm invasion Direct invasion of lobe at least T2a T3: Parietal pericardium T4: visceral pericardium T3: rib T4: Mediastinal fat T4: Pancoast with bone, vessel or nerve T3: Pancoast without bone vessel or nerve What about T stage? T stage based on Gross size in many tumors Include invasive size as well in a lepidic predominant tumor (?>50% or over) Lepidic predominant adenocarcinoma (2.5 cm) with area of invasion (1.0 cm). Microscopic invasive patterns acinar, papillary. How to adjust for invasive size? About grossing

18 Invasive size YES! Applies to tumors with non-mucinous lepidic component which are generally part solid by imaging. NO!

19

20 4.0 mm 1.8 cm total 0.5 cm solid

21 No need to correct for invasive size Two methods to adjust for invasive size Method 1 Linear extent Method 2 Percent x diameter

22 Method gross 1.3 cm invasive Method 2 13% invasive (used pixel area) 85% lepidic 15% invasive? Equals 4.2 mm Invasive size Chronic headache - Classification Method gross 1.3 cm invasive size 3.2 cm 1.2 cm solid Method 2 13% invasive (used pixel area) 85% lepidic 15% invasive?equals 4.2 mm Invasive size Measure invasion to distinguish AIS from MIA from LPA Enumerate primary pattern Mention high grade pattern such as micropapillary WHO recommends enumeration of patterns to 5% increments

23 Bigger headache Multiple nodules Several scenarios establish multiple nodules as multiple primaries Biggest headache Staging and invasive size Size criteria have new strata Correction for invasive size in lepidic predominant tumors

Classification of non-small cell lung carcinomas (NSCLC)

Classification of non-small cell lung carcinomas (NSCLC) Classification of non-small cell lung carcinomas (NSCLC) 1. NordiQC Conference on Standardization in Applied Immunohistochemistry 4-7 June 2013 Birgit Guldhammer Skov, MD. DMeSci, Dept. Of Pathology, Rigshospitalet,

More information

MOLECULAR PREDICTIVE MARKERS OF LUNG CARCINOMA: KFSH&RC EXPERIENCE

MOLECULAR PREDICTIVE MARKERS OF LUNG CARCINOMA: KFSH&RC EXPERIENCE 25 th IAP-Arab Division Conference 07-09 November 2013, Amman, Jordan MOLECULAR PREDICTIVE MARKERS OF LUNG CARCINOMA: KFSH&RC EXPERIENCE Fouad Al Dayel, MD, FRCPA, FRCPath Professor and Chairman Department

More information

International association for the study of lung cancer/american thoracic society/european respiratory

International association for the study of lung cancer/american thoracic society/european respiratory International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. William Travis, Elisabeth

More information

Steering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD.

Steering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD. Steering Committee Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD MD, PhD Waiting on photo Paul Van Schil, MD, PhD William D. Travis, MD Ming-Sound Tsao,

More information

3/23/2017. Disclosure of Relevant Financial Relationships. Pathologic Staging Updates in Lung Cancer T STAGE OUTLINE SURVIVAL ACCORDING TO SIZE ONLY

3/23/2017. Disclosure of Relevant Financial Relationships. Pathologic Staging Updates in Lung Cancer T STAGE OUTLINE SURVIVAL ACCORDING TO SIZE ONLY Pathologic Staging Updates in Lung Cancer Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME

More information

Steering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD.

Steering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD. Steering Committee Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD MD, PhD Waiting on photo Paul Van Schil, MD, PhD William D. Travis, MD Ming-Sound Tsao,

More information

Original Article Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma

Original Article Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma Int J Clin Exp Pathol 2014;7(11):8039-8045 www.ijcep.com /ISSN:1936-2625/IJCEP0002211 Original Article Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification

More information

Ground Glass Opacities

Ground Glass Opacities Ground Glass Opacities A pathologist s perspective Marie-Christine Aubry, M.D. Professor of Pathology Mayo Clinic Objectives Discuss the proposed new pathologic classification of adenocarcinoma with historical

More information

Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis

Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis 19 th Congress of APSR PG of Lung Cancer (ESAP): Update of Lung Cancer Thoracic CT pattern in lung cancer: correlation of CT and pathologic diagnosis Kazuma Kishi, M.D. Department of Respiratory Medicine,

More information

OBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.

OBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules. Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management

More information

Histopathology of NSCLC, IHC markers and ptnm classification

Histopathology of NSCLC, IHC markers and ptnm classification ESMO Preceptorship on Non-Small Cell Lung Cancer November 15 th & 16 th 2017 Singapore Histopathology of NSCLC, IHC markers and ptnm classification Prof Keith M Kerr Department of Pathology, Aberdeen University

More information

I appreciate the courtesy of Kusumoto at NCC for this presentation. What is Early Lung Cancers. Early Lung Cancers. Early Lung Cancers 18/10/55

I appreciate the courtesy of Kusumoto at NCC for this presentation. What is Early Lung Cancers. Early Lung Cancers. Early Lung Cancers 18/10/55 I appreciate the courtesy of Kusumoto at NCC for this presentation. Dr. What is Early Lung Cancers DEATH Early period in its lifetime Curative period in its lifetime Early Lung Cancers Early Lung Cancers

More information

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss

More information

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.

Update on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved. 1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of

More information

Non-Small Cell Lung Carcinoma - Myers

Non-Small Cell Lung Carcinoma - Myers Role of Routine Histology and Special Testing in Managing Patients with Non- Small Cell Lung Carcinoma Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of

More information

Pulmonary Nodules & Masses

Pulmonary Nodules & Masses Pulmonary Nodules & Masses A Diagnostic Approach Heber MacMahon The University of Chicago Department of Radiology Disclosure Information Consultant for Riverain Technology Minor equity in Hologic Royalties

More information

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study 1574 & 2012 USCAP, Inc. All rights reserved 0893-3952/12 $32.00 Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study Erik Thunnissen

More information

How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed?

How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? Original Article How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? Yoshihisa Kobayashi, MD,* Takayuki Fukui, MD,* Simon Ito, MD,* Noriyasu Usami, MD,* Shunzo Hatooka, MD,* Yasushi

More information

The new international multidisciplinary lung adenocarcinoma

The new international multidisciplinary lung adenocarcinoma Eur Respir J 2011; 38: 239 243 DOI: 10.1183/09031936.00026711 CopyrightßERS 2011 EDITORIAL Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification W.D. Travis*,"",

More information

The 8th Edition of the TNM Classification for Lung Cancer Background, Innovations and Implications for Clinical Practice

The 8th Edition of the TNM Classification for Lung Cancer Background, Innovations and Implications for Clinical Practice The 8th Edition of the TNM Classification for Lung Cancer Background, Innovations and Implications for Clinical Practice University of Torino Lecture 28th June 2017 Torino, Italy Ramón Rami-Porta Thoracic

More information

Lung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology

Lung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology Lung Neoplasia II Resection specimens Pathobasic Lukas Bubendorf Pathology Agenda Preneoplastic lesions Histological subtypes of lung cancer Histological patterns of AC Cells of origin and characteristic

More information

The Spectrum of Management of Pulmonary Ground Glass Nodules

The Spectrum of Management of Pulmonary Ground Glass Nodules The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral

More information

Lung cancer is now a major cause of death in developed

Lung cancer is now a major cause of death in developed Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,

More information

8/22/2016. Major risk factors for the development of lung cancer are: Outline

8/22/2016. Major risk factors for the development of lung cancer are: Outline Carcinomas of the Lung: Changes in Staging, Adenocarcinoma Classification and Genetics Grace Y. Lin, M.D., Ph.D. Outline Background Staging of Lung Cancer: Review of the 2010 7 th Edition of the AJCC Cancer

More information

Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas

Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas Ye et al. World Journal of Surgical Oncology 2014, 12:42 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas Bo

More information

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel. Lung NAACCR 2018 2019 WEBINAR SERIES 1 Q&A Please submit all questions concerning the webinar content through the Q&A panel. If you have participants watching this webinar at your site, please collect

More information

Should minimally invasive lung adenocarcinoma be transferred from stage IA1 to stage 0 in future updates of the TNM staging system?

Should minimally invasive lung adenocarcinoma be transferred from stage IA1 to stage 0 in future updates of the TNM staging system? Original Article Should minimally invasive lung adenocarcinoma be transferred from stage to stage 0 in future updates of the TNM staging system? Tianxiang Chen 1,2#, Jizhuang Luo 3#, Haiyong Gu 3, Yu Gu

More information

THE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS

THE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS THE IASLC/ERS/ATS ADENOCARCINOMA CLASSIFICATION RATIONALE AND STRENGTHS PULMONARY PATHOLOGY SOCIETY USCAP, BALTIMORE, March 2, 2013 William D. Travis, M.D. Dept of Pathology, Memorial Sloan-Kettering Cancer

More information

The small subsolid pulmonary nodules. What radiologists need to know.

The small subsolid pulmonary nodules. What radiologists need to know. The small subsolid pulmonary nodules. What radiologists need to know. Poster No.: C-1250 Congress: ECR 2016 Type: Educational Exhibit Authors: L. Fernandez Rodriguez, A. Martín Díaz, A. Linares Beltrán,

More information

Lung cancer continues to be the leading cause of cancer

Lung cancer continues to be the leading cause of cancer original article Why Do Pathological Stage IA Lung Adenocarcinomas Vary from Prognosis? A Clinicopathologic Study of 176 Patients with Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS

More information

Original Article Thymidine kinase 1 is a better prognostic marker than Ki-67 for pt1 adenocarcinoma of the lung

Original Article Thymidine kinase 1 is a better prognostic marker than Ki-67 for pt1 adenocarcinoma of the lung Int J Clin Exp Med 2014;7(8):2120-2128 www.ijcem.com /ISSN:1940-5901/IJCEM1402040 Original Article Thymidine kinase 1 is a better prognostic marker than Ki-67 for pt1 adenocarcinoma of the lung Yan Xu

More information

CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC)

CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC) CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC) Poster No.: C-2192 Congress: ECR 2014 Type: Educational Exhibit Authors: I. Sandu, A. R. Popita, I.-A. Brumboiu; Cluj-Napoca/RO

More information

CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC)

CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC) CT findings in multifocal or diffuse non-mucinous bronchioloalveolar carcinoma (BAC) Poster No.: C-2192 Congress: ECR 2014 Type: Educational Exhibit Authors: I. Sandu, A. R. Popita, I.-A. Brumboiu; Cluj-Napoca/RO

More information

The revised lung adenocarcinoma classification an imaging guide

The revised lung adenocarcinoma classification an imaging guide Review Article The revised lung adenocarcinoma classification an imaging guide Natasha Gardiner 1, Sanjay Jogai 2, Adam Wallis 3 1 Specialty Registrar in Clinical Radiology, Wessex Deanery, UK; 2 Consultant

More information

The lung adenocarcinoma guidelines: what to be considered by surgeons

The lung adenocarcinoma guidelines: what to be considered by surgeons Review Article The lung adenocarcinoma guidelines: what to be considered by surgeons Rodrigo A. S. Sardenberg 1, Evandro Sobroza Mello 1, Riad N. Younes 2 1 Hospital Alemão Oswaldo Cruz, São Paulo, Brazil;

More information

Lung cancer is the most common cause of cancer death in

Lung cancer is the most common cause of cancer death in ORIGINAL ARTICLE Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features? Catherine

More information

Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma

Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma Original Article Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma Yingying Miao 1,2 *, Jianya Zhang 1,2 *, Jiawei Zou 1,2, Qingqing

More information

The histological grading of lung cancer is a significant

The histological grading of lung cancer is a significant ORIGINAL ARTICLE Interobserver Agreement in the Nuclear Grading of Primary Pulmonary Adenocarcinoma Yoshimasa Nakazato, MD,* Akiko Miyagi Maeshima, MD, Yuichi Ishikawa, MD, Yasushi Yatabe, MD, Junya Fukuoka,

More information

Prognostic factors in curatively resected pathological stage I lung adenocarcinoma

Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,

More information

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new

More information

Protocol for the Examination of Specimens From Patients With Primary Non-Small Cell Carcinoma, Small Cell Carcinoma, or Carcinoid Tumor of the Lung

Protocol for the Examination of Specimens From Patients With Primary Non-Small Cell Carcinoma, Small Cell Carcinoma, or Carcinoid Tumor of the Lung Protocol for the Examination of Specimens From Patients With Primary Non-Small Cell Carcinoma, Small Cell Carcinoma, or Carcinoid Tumor of the Lung Version: Protocol Posting Date: June 2017 Includes ptnm

More information

LUNG NODULES: MODERN MANAGEMENT STRATEGIES

LUNG NODULES: MODERN MANAGEMENT STRATEGIES Department of Radiology LUNG NODULES: MODERN MANAGEMENT STRATEGIES Christian J. Herold M.D. Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna, Austria Pulmonary

More information

Case Report Multfocal micronodular pneumocyte hyperplasia in a Chinese man masquerading as miliary tuberculosis

Case Report Multfocal micronodular pneumocyte hyperplasia in a Chinese man masquerading as miliary tuberculosis Int J Clin Exp Pathol 2015;8(2):2165-2170 www.ijcep.com /ISSN:1936-2625/IJCEP0004730 Case Report Multfocal micronodular pneumocyte hyperplasia in a Chinese man masquerading as miliary tuberculosis Qi Sun

More information

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung

More information

Research Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma

Research Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma BioMed Research International, Article ID 64568, 6 pages http://dx.doi.org/.55/24/64568 Research Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically

More information

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.

More information

FDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D.

FDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D. FDG PET/CT in Lung Cancer Read with the experts Homer A. Macapinlac, M.D. Patient with suspected lung cancer presents with left sided chest pain T3 What is the T stage of this patient? A) T2a B) T2b C)

More information

The 8th Edition Lung Cancer Stage Classification

The 8th Edition Lung Cancer Stage Classification The 8th Edition Lung Cancer Stage Classification Elwyn Cabebe, M.D. Medical Oncology, Hematology, and Hospice and Palliative Care Valley Medical Oncology Consultants Director of Quality, Medical Oncology

More information

Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק

Non Small Cell Lung Cancer Histopathology דר יהודית זנדבנק Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC

More information

Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor

Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor Cho et al. BMC Pulmonary Medicine (2018) 18:151 https://doi.org/10.1186/s12890-018-0709-2 RESEARCH ARTICLE Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor

More information

PET CT for Staging Lung Cancer

PET CT for Staging Lung Cancer PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct

More information

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical

More information

Imaging of Lung Cancer: A Review of the 8 th TNM Staging System

Imaging of Lung Cancer: A Review of the 8 th TNM Staging System Imaging of Lung Cancer: A Review of the 8 th TNM Staging System Travis S Henry, MD Associate Professor of Clinical Radiology Cardiac and Pulmonary Imaging Section University of California, San Francisco

More information

Uniportal video-assisted thoracoscopic surgery segmentectomy

Uniportal video-assisted thoracoscopic surgery segmentectomy Case Report on Thoracic Surgery Page 1 of 5 Uniportal video-assisted thoracoscopic surgery segmentectomy John K. C. Tam 1,2 1 Division of Thoracic Surgery, National University Heart Centre, Singapore;

More information

Multifocal Lung Cancer

Multifocal Lung Cancer Multifocal Lung Cancer P. De Leyn, MD, PhD Department of Thoracic Surgery University Hospitals Leuven Belgium LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery Department of Pneumology Department

More information

Second predominant subtype predicts outcomes of intermediatemalignant invasive lung adenocarcinoma

Second predominant subtype predicts outcomes of intermediatemalignant invasive lung adenocarcinoma European Journal of Cardio-Thoracic Surgery 51 (2017) 218 222 doi:10.1093/ejcts/ezw318 Advance Access publication 6 October 2016 ORIGINAL ARTICLE Cite this article as: Ito M, Miyata Y, Yoshiya T, Tsutani

More information

Surgical pathology of early stage non-small cell lung carcinoma

Surgical pathology of early stage non-small cell lung carcinoma Review Article Page 1 of 8 Surgical pathology of early stage non-small cell lung carcinoma Mary Beth Beasley 1, Francine R. Dembitzer 1, Raja M. Flores 2 1 Department of Pathology, 2 Department of Thoracic

More information

Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma

Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma REVIEW C URRENT OPINION Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma Wilko Weichert and Arne Warth Purpose of

More information

Impact of immunostaining of pulmonary and mediastinal cytology

Impact of immunostaining of pulmonary and mediastinal cytology Impact of immunostaining of pulmonary and mediastinal cytology Harman Sekhon MD, PhD Director of Cytopathology Head of Ottawa-site Ontario Tumour Bank June 20, 2014 Disclaimer Pfizer: Honorarium-Advisory

More information

A Multi-Resolution Deep Learning Framework for Lung Adenocarcinoma Growth Pattern Classification

A Multi-Resolution Deep Learning Framework for Lung Adenocarcinoma Growth Pattern Classification MIUA2018, 053, v4 (final): Multi-Resolution CNN for Lung Growth Pattern Classification 1 A Multi-Resolution Deep Learning Framework for Lung Adenocarcinoma Growth Pattern Classification Najah Alsubaie

More information

Wenjing Xiang 1,2, Yanfen Xing 2, Sen Jiang 2, Gang Chen 2, Haixia Mao 2, Kanchan Labh 2, Xiaoli Jia 2 and Xiwen Sun 2*

Wenjing Xiang 1,2, Yanfen Xing 2, Sen Jiang 2, Gang Chen 2, Haixia Mao 2, Kanchan Labh 2, Xiaoli Jia 2 and Xiwen Sun 2* Xiang et al. Cancer Imaging 2014, 14:33 RESEARCH ARTICLE Open Access Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring 10 mm on thin-section

More information

Xiaohuan Pan 1,2 *, Xinguan Yang 1,2 *, Jingxu Li 1,2, Xiao Dong 1,2, Jianxing He 2,3, Yubao Guan 1,2. Original Article

Xiaohuan Pan 1,2 *, Xinguan Yang 1,2 *, Jingxu Li 1,2, Xiao Dong 1,2, Jianxing He 2,3, Yubao Guan 1,2. Original Article Original Article Is a 5-mm diameter an appropriate cut-off value for the diagnosis of atypical adenomatous hyperplasia and adenocarcinoma in situ on chest computed tomography and pathological examination?

More information

Lecture Goals. Lung (Bronchogenic) Cancer. Causes of Lung Cancer. Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic

Lecture Goals. Lung (Bronchogenic) Cancer. Causes of Lung Cancer. Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic Lecture Goals Origin of Lung Cancer Subtypes New Treatment Paradigms in Lung Cancer Overview of Lung Cancer Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic Lung (Bronchogenic)

More information

Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule

Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule Original Article Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule Jong Hui Suh 1, Jae Kil Park 2, Youngkyu Moon 2 1 Department of Thoracic & Cardiovascular Surgery,

More information

PET/CT in lung cancer

PET/CT in lung cancer PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of

More information

Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma

Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma ORIGINAL ARTICLE Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Jhingook Kim, MD, PhD,* Young Mog Shim, MD,

More information

A case of different EGFR mutations in surgically resected synchronous triple lung cancer

A case of different EGFR mutations in surgically resected synchronous triple lung cancer Case Report A case of different EGFR mutations in surgically resected synchronous triple lung cancer Naoki Haratake 1, Mitsuhiro Takenoyama 1, Makoto Edagawa 1, Shinichiro Shimamatsu 1, Ryo Toyozawa 1,

More information

YOUR LUNG CANCER PATHOLOGY REPORT

YOUR LUNG CANCER PATHOLOGY REPORT UNDERSTANDING SERIES YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...2 The Basics...3 Sections of a Pathology Report...6

More information

Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis

Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis Ann Surg Oncol (2016) 23:2099 2105 DOI 10.1245/s10434-015-5043-9 ORIGINAL ARTICLE THORACIC ONCOLOGY Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph

More information

Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer

Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department

More information

Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations

Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations Original Article Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations Youngkyu Moon 1, Kyo Young Lee 2, Sook Whan Sung 1, Jae Kil Park 1 1 Department of

More information

Does the lung nodule look aggressive enough to warrant a more extensive operation?

Does the lung nodule look aggressive enough to warrant a more extensive operation? Accepted Manuscript Does the lung nodule look aggressive enough to warrant a more extensive operation? Michael Kuan-Yew Hsin, MBChB, MA, FRCS(CTh), David Chi-Leung Lam, MD, PhD, FRCP (Edin, Glasg & Lond)

More information

HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules

HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules Original Article HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules Wei Yu 1, Zhaoyu Wang 2, Liyong Qian 2, Shanjun Wang

More information

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder:

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder: 1 NAACCR 2015-2016 Webinar Series Collecting Cancer Data: Lung NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org Q&A Please submit all

More information

Clinicopathological Features and Computed Tomographic Findings of 52 Surgically Resected

Clinicopathological Features and Computed Tomographic Findings of 52 Surgically Resected Clinicopathological Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung Yukio Watanabe, MD, 1,4 Koji Tsuta, MD, 1 Masahiko Kusumoto, MD, 2 Akihiko

More information

Collaborative Stage. Site-Specific Instructions - LUNG

Collaborative Stage. Site-Specific Instructions - LUNG Slide 1 Collaborative Stage Site-Specific Instructions - LUNG In this presentation, we are going to review the AJCC Cancer Staging criteria for the lung primary site. Slide 2 Reading Assignments As each

More information

Prudence Anne Russell 1,2, Gavin Michael Wright 3,4

Prudence Anne Russell 1,2, Gavin Michael Wright 3,4 Editorial Page 1 of 7 Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail? Prudence Anne Russell

More information

The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view

The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view Review Article The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view Wentao Fang 1, Yangwei Xiang 1, Chenxi Zhong 1, Qunhui Chen 2 1 Department of Thoracic Surgery, 2 Department

More information

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 Hisao Asamura, MD, a Tomoyuki Hishida, MD, b Kenji Suzuki, MD, c Teruaki Koike,

More information

AJCC-NCRA Education Needs Assessment Results

AJCC-NCRA Education Needs Assessment Results AJCC-NCRA Education Needs Assessment Results Donna M. Gress, RHIT, CTR Survey Tool 1 Survey Development, Delivery, Analysis THANKS to NCRA for the following work Developed survey with input from partners

More information

An Update: Lung Cancer

An Update: Lung Cancer An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology

More information

ONLINE CONTINUING EDUCATION ACTIVITY

ONLINE CONTINUING EDUCATION ACTIVITY ONLINE CONTINUING EDUCATION ACTIVITY Take free quizzes online at acsjournals.com/ce ARTICLE TITLE: Lung Cancer Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual

More information

Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1

Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression of transforming growth factor-β1 Imai et al. World Journal of Surgical Oncology 2013, 11:113 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Bronchioloalveolar invasion in non-small cell lung cancer is associated with expression

More information

Dynamic Risk Stratification:

Dynamic Risk Stratification: Dynamic Risk Stratification: Using Risk Estimates to Guide Initial Management R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine

More information

The ABCs of BAC: Bronchioloalveolar Carcinoma

The ABCs of BAC: Bronchioloalveolar Carcinoma The ABCs of BAC: Bronchioloalveolar Carcinoma Howard (Jack) West, MD Medical Oncologist Medical Director, Thoracic Oncology Program Swedish Cancer Institute Seattle, WA March, 2009 President & CEO GRACE

More information

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma July 2016 New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma Contributed by: Laurel Rose, MD, Resident Physician, Indiana University School of Medicine,

More information

Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer

Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Original Article Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer Feichao Bao, Ping Yuan, Xiaoshuai Yuan, Xiayi Lv, Zhitian Wang, Jian Hu Department

More information

Pathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection

Pathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection GENERAL THORACIC Pathology and Prognosis of Persistent Stable Pure Ground-Glass Opacity Nodules After Surgical Resection Sukki Cho, MD, HeeChul Yang, MD, Kwhanmien Kim, MD, and Sanghoon Jheon, MD Department

More information

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer [Based on WOSCAN NSCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED

More information

6 th Reprint Handbook Pages AJCC 7 th Edition

6 th Reprint Handbook Pages AJCC 7 th Edition 6 th Reprint Handbook Pages AJCC 7 th Edition AJCC 7 th Edition Errata for 6 th Reprint Table 1 Handbook No Significant Staging Clarifications for 6 th Reprint AJCC 7 th Edition Errata for 6 th Reprint

More information

Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion

Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion Early-stage locally advanced non-small cell lung cancer (NSCLC) Clinical Case Discussion Pieter Postmus The Clatterbridge Cancer Centre Liverpool Heart and Chest Hospital Liverpool, United Kingdom 1 2

More information

Extensive immunohistochemistry was performed on this case, in the referring community /district hospital. This showed the following results:

Extensive immunohistochemistry was performed on this case, in the referring community /district hospital. This showed the following results: Case 1 The New Classification Helped Keith Kerr Clinical history This 75 year old female patient presented with an increasing cough and some vague symptoms of pain over the left lower chest wall. She is

More information

Steering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD.

Steering Committee. Waiting on photo. Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD. Steering Committee Paul A. Bunn, Jr., MD Kavita Garg, MD Kim Geisinger, MD Fred R. Hirsch, Gregory Riely, MD, PhD MD, PhD Waiting on photo Paul Van Schil, MD, PhD William D. Travis, MD Ming-Sound Tsao,

More information

Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening

Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening Guidelines for the Management of Pulmonary Nodules Detected by Low-dose CT Lung Cancer Screening 1. Introduction In January 2005, the Committee for Preparation of Clinical Practice Guidelines for the Management

More information

Select problems in cystic pancreatic lesions

Select problems in cystic pancreatic lesions Disclosure Select problems in cystic pancreatic lesions Five Prime Therapeutics shareholder Adicet Bio shareholder Bristol-Meyer Squibb advisory board grace.kim@ucsf.edu Pancreatic cystic lesions Intraductal

More information

Lung imaging. Sebastian Ley 1,2

Lung imaging. Sebastian Ley 1,2 CLINICAL YEAR IN REVIEW LUNG IMAGING Lung imaging Sebastian Ley 1,2 Affiliations: 1 Dept of Diagnostic and Interventional Radiology, Chirurgische Klinik Dr. Rinecker, Munich, Germany. 2 Dept of Clinical

More information

Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung

Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung ORIGINAL ARTICLE Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung Potential Parameters for a Grading System Jan H. von der Thüsen, MD,

More information

Chest Radiology Interpretation: Findings of Tuberculosis

Chest Radiology Interpretation: Findings of Tuberculosis Chest Radiology Interpretation: Findings of Tuberculosis Get out your laptops, smart phones or other devices pollev.com/chestradiology Case #1 1 Plombage Pneumonia Cancer 2 Reading the TB CXR Be systematic!

More information

Lung cancer is the leading cause of cancer-related

Lung cancer is the leading cause of cancer-related Original Articles Correlation of Mutation Status With Predominant Histologic Subtype of Adenocarcinoma According to the New Lung Adenocarcinoma Classification of the International Association for the Study

More information

Collecting Cancer Data: Lung

Collecting Cancer Data: Lung Collecting Cancer Data: Lung NAACCR 2011 2012 Webinar Series 2/2/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information